These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

85 related items for PubMed ID: 1674964

  • 21. Eprosartan provides safe and effective long-term maintenance of blood pressure control in patients with mild to moderate essential hypertension.
    Levine B.
    Curr Med Res Opin; 2001; 17(1):8-17. PubMed ID: 11464450
    [Abstract] [Full Text] [Related]

  • 22. [Anti-hypertensive efficacy and tolerability of sustained-release prazosin hydrochloride. A Brazilian multicenter study].
    Spritzer N.
    Arq Bras Cardiol; 1990 Oct; 55(4):263-6. PubMed ID: 2078143
    [Abstract] [Full Text] [Related]

  • 23. [Prazosin in the treatment of hypertension: effect on lipid metabolism].
    Hitzenberger G, Neumann K, Dietz S, Egger H, Hariri K, Kittler E, Niedrist W, Nitsch-Fritz R, Ravanelli O, Sapinsky H.
    Wien Med Wochenschr; 1987 Nov 30; 137(22):525-30. PubMed ID: 3433787
    [Abstract] [Full Text] [Related]

  • 24. [Efficacy of and tolerance to prolonged release prazosin in patients with hypertension and non-insulin dependent diabetes].
    Hanon O, Giacomino A, Troy S, Bernaud C, Girerd X, Weber S.
    Ann Cardiol Angeiol (Paris); 2000 Oct 30; 49(7):390-6. PubMed ID: 12555491
    [Abstract] [Full Text] [Related]

  • 25. Terazosin. A review of its pharmacodynamic and pharmacokinetic properties, and therapeutic efficacy in essential hypertension.
    Titmarsh S, Monk JP.
    Drugs; 1987 May 30; 33(5):461-77. PubMed ID: 2885169
    [Abstract] [Full Text] [Related]

  • 26. Multicentric, clinical trial of S-Amlodipine 2.5 mg versus Amlodipine 5 mg in the treatment of mild to moderate hypertension--a randomized, double-blind clinical trial.
    Pathak L, Hiremath, Kerkar PG, Manade VG.
    J Assoc Physicians India; 2004 Mar 30; 52():197-202. PubMed ID: 15636308
    [Abstract] [Full Text] [Related]

  • 27.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 28.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 29. The effects of terazosin and methyclothiazide on blood pressure and serum lipids.
    Luther RR, Glassman HN, Estep CB, Maurath CJ, Jordan DC.
    Am Heart J; 1989 Apr 30; 117(4):842-7. PubMed ID: 2564723
    [Abstract] [Full Text] [Related]

  • 30. [Dose-response study of bunazosin in the treatment of light-to-moderate arterial hypertension].
    Marchegiano R, Lamenza F, Sarno D, Tozzi N, Fontana D, De Luca N.
    Minerva Cardioangiol; 1993 Oct 30; 41(10):451-6. PubMed ID: 7905614
    [Abstract] [Full Text] [Related]

  • 31. [Effects of terazosine and atenolol on serum lipids in essential hypertension].
    Bur A, Woisetschläger C, Herkner H, Derhaschnig U, Quehenberger P, Hirschl MM.
    Z Kardiol; 2002 Sep 30; 91(9):685-92. PubMed ID: 12448067
    [Abstract] [Full Text] [Related]

  • 32. Comparison of the safety and efficacy of once-daily terazosin versus twice-daily prazosin for the treatment of mild to moderate hypertension.
    Deger G.
    Am J Med; 1986 May 23; 80(5B):62-7. PubMed ID: 2872809
    [Abstract] [Full Text] [Related]

  • 33. Terazosin, a new selective alpha 1-adrenergic blocking agent. Results of long-term treatment in patients with essential hypertension.
    Luther RR, Glassman HN, Estep CB, Schmitz PJ, Horton JK, Jordan DC.
    Am J Hypertens; 1988 Jul 23; 1(3 Pt 3):237S-240S. PubMed ID: 2901267
    [Abstract] [Full Text] [Related]

  • 34. Safety assessment of terazosin in the treatment of patients with symptomatic benign prostatic hyperplasia: a combined analysis.
    Lowe FC.
    Urology; 1994 Jul 23; 44(1):46-51. PubMed ID: 7518981
    [Abstract] [Full Text] [Related]

  • 35. Terazosin: an effective once-daily monotherapy for the treatment of hypertension.
    Dauer AD.
    Am J Med; 1986 May 23; 80(5B):29-34. PubMed ID: 2872804
    [Abstract] [Full Text] [Related]

  • 36. Efficacy of terazosin in the treatment of essential hypertension in blacks.
    Luther RR, Klepper MJ, Maurath CJ, Glassman HN, Achari R, Laddu AR.
    J Hum Hypertens; 1990 Apr 23; 4(2):151-3. PubMed ID: 1971027
    [Abstract] [Full Text] [Related]

  • 37. Long-term efficacy and safety of terazosin alone and in combination with other antihypertensive agents.
    Cohen JD.
    Am Heart J; 1991 Sep 23; 122(3 Pt 2):919-25. PubMed ID: 1678923
    [Abstract] [Full Text] [Related]

  • 38. Effect of terazosin on serum lipids.
    Deger G.
    Am J Med; 1986 May 23; 80(5B):82-5. PubMed ID: 2872813
    [Abstract] [Full Text] [Related]

  • 39. Long-term experience with terazosin for treatment of mild to moderate hypertension.
    Mersey JH.
    Am J Med; 1986 May 23; 80(5B):68-72. PubMed ID: 2872810
    [Abstract] [Full Text] [Related]

  • 40. Alpha 2-agonist versus alpha 1-antagonist in mild-to-moderate hypertension: comparison of transdermal clonidine and terazosin monotherapies.
    Harris SI, Alvarez C.
    Am J Ther; 1997 Jan 23; 4(1):9-15. PubMed ID: 10423584
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 5.